AccessibilityHelp
InnovAge logo

InnovAge(NASDAQ) INNV

Market Cap$1.30BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2021)-61%
5 Year+42%
1 Year+83%
1 Month+6%
Premium Feature
Moneyball Superscore
58/100
$9.53
+0.05%
+0.01Today
After hours$9.55+$0.02 (+0.26%)
InnovAge last closing stock price
MetricPriceDate
Last closeUSD 9.552026-10-23
InnovAge stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+7.91%USD 8.852026-10-16
1 month+6.11%USD 9.002026-09-23
3 month-17.39%USD 11.562026-07-24
Year to date+84.01%USD 5.192025-12-31
1 year+82.95%USD 5.222025-10-23
3 year+80.19%USD 5.302023-10-24
5 year+41.9%USD 6.732021-10-22
Since inception-60.54%USD 24.202021-03-04

InnovAge Financials at a Glance

Market Cap

$1.30BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$989.71M

Net Income (TTM)

-$2.54M

EPS (TTM)

-$0.02

P/E Ratio

-472.77

Dividend

$0.00

Beta (Volatility)

1.22 (Average)

Price

$9.53

Volume

460,862.832

Open

$9.53

Previous Close

$9.55

Daily Range

$9.40 - $9.70

52-Week Range

$3.94 - $12.64

Estimated Earnings Date

Nov 3, 2026

INNV News

Foolcom-Featured.png

InnovAge Revenue Jumps 11% in Fiscal Q4

Motley Fool Markets TeamSep 9, 2025
Women unhappy with body temperature reading

Why InnovAge Stock Dived by 11% Today

Eric VolkmanDec 27, 2021

INNV: Motley Fool Moneyball Superscore

58

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About InnovAge

InnovAge Holding NASDAQ:INNV helps frail seniors live independently at home. It coordinates medical and social care for seniors needing nursing support. The company manages health needs through a single monthly payment.

One Plan for Everything

  • Clinical Care Centers: Medical hubs offering primary care, physical therapy, and social activities; part of the PACE segment representing nearly 100% of revenue.
  • In-Home Services: Skilled and unskilled personal care delivered directly to the residence of a participant.
  • Logistics and Nutrition: Transportation to medical appointments and daily prepared meals for enrolled seniors.
  • Pharmacy Management: Prescription drug services managed through in-house assets and specialized partners.

Growing the Care Network

  • Ramped up new centers in Tampa and Orlando during fiscal year 2026.
  • Formed joint ventures with Orlando Health and Tampa General Hospital to expand community outreach.
  • Acquired pharmacy assets from Tabula Rasa HealthCare Group in fiscal year 2025 to manage costs.
  • Completed the acquisition of two Program of All-Inclusive Care for the Elderly (PACE) organizations during fiscal year 2024.

Taking on Financial Risk

InnovAge operates as a fully capitated provider, meaning it accepts 100% of the financial risk for all participant care. This model encourages preventative treatment and coordinated management to avoid expensive hospital stays and nursing home admissions.

A Look at the Numbers

  • Total revenue was $989.7 million in fiscal year 2026, up 15.9% year over year.
  • Net loss improved to $0.7 million in fiscal year 2026, down from $35.3 million in fiscal year 2025.
  • Adjusted EBITDA reached $94.6 million in fiscal year 2026, representing a 174% year-over-year increase.
  • The company served approximately 8,230 participants across 20 centers as of June 30, 2026.

Company Evolution

InnovAge has transitioned from a regional non-profit to the largest for-profit provider of integrated senior care in the United States. Its platform manages complex health needs through a value-based model designed to reduce total government healthcare spending.

AI Generated • Oct 15, 2026

Industry

Healthcare Providers and Services

Sector

Health Care

Employees

2,500

CEO

Patrick Blair, MBA

Website

www.innovage.com

Headquarters

Denver, CO 80230, US

INNV Financials

Key Financial Metrics (TTM)

Gross Margin

21.39%

Operating Margin

6.39%

Net Income Margin

-0.26%

Return on Equity

-1.05%

Return on Capital

20.55%

Return on Assets

-0.46%

Earnings Yield

-0.21%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$1.30BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

136.45M

Volume

460.86K

Avg. Volume

500.89K

Financials (TTM)

Gross Profit

$211.71M

Operating Income

$63.22M

EBITDA

$31.27M

Operating Cash Flow

$64.79M

Capital Expenditure

-$14.31M

Free Cash Flow

$50.48M

Cash & ST Invst.

$141.33M

Total Debt

$86.95M

InnovAge Performance Analysis

InnovAge annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20232023-06-30USD 688,087,000-1.5%
20242024-06-30USD 763,855,00011.0%
20252025-06-30USD 853,699,00011.8%
20262026-06-30USD 989,707,00015.9%
InnovAge sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q12025-09-308.2%
Q22025-12-311.5%
Q32026-03-315.1%
Q42026-06-304.0%
InnovAge annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20232023-06-30USD -0.30523.7%
20242024-06-30USD -0.16-47.7%
20252025-06-30USD -0.2242.6%
20262026-06-30USD -0.02-91.6%
InnovAge sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q12025-09-30175.0%
Q22025-12-3129.8%
Q32026-03-31-382.4%
Q42026-06-30127.3%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2026YOY CHG

Revenue

$261.95M

+20.1%

Gross Profit

$56.21M

+37.9%

Gross Margin

21.46%

N/A

Market Cap

$1.30BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$521.24K

N/A

Employees

2,500

N/A

Net Income

$8.29M

+172.8%

EBITDA

$22.40M

+444.3%

Quarterly Fundamentals

Name
Q4 2026YOY CHG

Total Cash

$141.33M

+33.4%

Total Debt

$86.95M

-14.0%

Accounts Receivable

$45.67M

+15.1%

Inventory

$0.00

N/A

Long Term Debt

$73.55M

-17.3%

Short Term Debt

$13.40M

+10.2%

Return on Assets

-0.46%

N/A

Return on Invested Capital

17.88%

N/A

Free Cash Flow

$17.02M

+214.7%

Operating Cash Flow

$21.29M

+215.3%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
PNTGThe Pennant Group, Inc.
$41.88-0.83%
SNDASonida Senior Living, Inc.
$33.82-0.15%
ADUSAddus HomeCare Corporation
$121.81-0.70%
BKDBrookdale Senior Living Inc.
$10.08-1.08%

Trending Stocks

Symbol / CompanyPricePrice Chg
SPCXSpace Exploration Technologies
$147.49+1.89%
TAT&T
$20.93-7.96%
SOXLDirexion Shares ETF Trust - Direxion Daily Semiconductor Bull 3x ETF
$83.56+1.77%
NUNu Holdings
$15.16+2.92%

Questions About INNV

What is the current price of InnovAge?

InnovAge is trading at $9.55 per share.

What is the 52-week range for InnovAge?

Over the past 52 weeks, InnovAge has traded between $3.94 and $12.64.

How much debt does InnovAge have?

As of the most recent reporting period, InnovAge reported total debt of $86.95M.

How much cash does InnovAge have on hand?

InnovAge reported $97.90M in cash and cash equivalents in its most recent financial results.

What is InnovAge’s dividend yield?

InnovAge does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services